Log in

NYSE:ZBH - Zimmer Biomet Stock Price, Forecast & News

$148.53
+0.91 (+0.62 %)
(As of 12/8/2019 09:15 AM ET)
Today's Range
$147.78
Now: $148.53
$149.63
50-Day Range
$134.07
MA: $141.87
$148.50
52-Week Range
$96.99
Now: $148.53
$150.79
Volume707,280 shs
Average Volume762,540 shs
Market Capitalization$30.55 billion
P/E Ratio19.44
Dividend Yield0.65%
Beta1.15
Zimmer Biomet Holdings, Inc, together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone574-267-6131

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.93 billion
Cash Flow$17.68 per share
Book Value$55.28 per share

Profitability

Net Income$-379,200,000.00

Miscellaneous

Employees19,000
Market Cap$30.55 billion
Next Earnings Date2/7/2020 (Estimated)
OptionableOptionable

Receive ZBH News and Ratings via Email

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.


Zimmer Biomet (NYSE:ZBH) Frequently Asked Questions

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet declared a quarterly dividend on Tuesday, September 3rd. Investors of record on Monday, September 30th will be given a dividend of $0.24 per share on Thursday, October 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Friday, September 27th. View Zimmer Biomet's Dividend History.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings Inc (NYSE:ZBH) announced its earnings results on Tuesday, November, 5th. The medical equipment provider reported $1.77 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.75 by $0.02. The medical equipment provider had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Zimmer Biomet had a negative net margin of 1.14% and a positive return on equity of 13.71%. The company's revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.63 earnings per share. View Zimmer Biomet's Earnings History.

When is Zimmer Biomet's next earnings date?

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Friday, February 7th 2020. View Earnings Estimates for Zimmer Biomet.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of $7.75 -7.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.82. The company issued revenue guidance of flat to +0.5% to ~$7.9-8.3 billion, compared to the consensus revenue estimate of $7.95 billion.

What price target have analysts set for ZBH?

23 analysts have issued 1-year target prices for Zimmer Biomet's stock. Their forecasts range from $108.00 to $170.00. On average, they expect Zimmer Biomet's share price to reach $147.60 in the next twelve months. This suggests that the stock has a possible downside of 0.6%. View Analyst Price Targets for Zimmer Biomet.

What is the consensus analysts' recommendation for Zimmer Biomet?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 4 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zimmer Biomet.

Has Zimmer Biomet been receiving favorable news coverage?

News stories about ZBH stock have trended very negative recently, InfoTrie reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Zimmer Biomet earned a news sentiment score of -3.7 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Zimmer Biomet.

Who are some of Zimmer Biomet's key competitors?

What other stocks do shareholders of Zimmer Biomet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Celgene (CELG), UnitedHealth Group (UNH), Walt Disney (DIS), Visa (V), NVIDIA (NVDA), Bristol-Myers Squibb (BMY) and Chevron (CVX).

Who are Zimmer Biomet's key executives?

Zimmer Biomet's management team includes the folowing people:
  • Mr. Bryan C. Hanson, Pres, CEO & Director (Age 52)
  • Mr. Daniel P. Florin Sr., Exec. VP & CFO (Age 55)
  • Mr. Chad F. Phipps, Sr. VP, Gen. Counsel & Sec. (Age 47)
  • Mr. Sang Yi, Pres of Asia Pacific (Age 57)
  • Mr. Ivan Tornos, Group Pres of Orthopedics (Age 43)

Who are Zimmer Biomet's major shareholders?

Zimmer Biomet's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (5.38%), State Street Corp (4.04%), Boston Partners (1.88%), Wedge Capital Management L L P NC (0.47%), Focused Investors LLC (0.45%) and Sumitomo Mitsui Trust Holdings Inc. (0.39%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Katarzyna Mazur-Hofsaess, Michael J Farrell, Michael W Michelson, Sang Yi, Syed A Jafry and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

Which institutional investors are selling Zimmer Biomet stock?

ZBH stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Squarepoint Ops LLC, Man Group plc, Focused Investors LLC, Wedge Capital Management L L P NC, State of New Jersey Common Pension Fund D, State Street Corp and Rothschild Investment Corp IL. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, Chad F Phipps, Didier Deltort and Sang Yi. View Insider Buying and Selling for Zimmer Biomet.

Which institutional investors are buying Zimmer Biomet stock?

ZBH stock was bought by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., California Public Employees Retirement System, Deroy & Devereaux Private Investment Counsel Inc., Voya Investment Management LLC, Douglas Lane & Associates LLC, Tamarack Advisers LP, Parametric Portfolio Associates LLC and Endurant Capital Management LP. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson and Syed A Jafry. View Insider Buying and Selling for Zimmer Biomet.

How do I buy shares of Zimmer Biomet?

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Zimmer Biomet's stock price today?

One share of ZBH stock can currently be purchased for approximately $148.53.

How big of a company is Zimmer Biomet?

Zimmer Biomet has a market capitalization of $30.55 billion and generates $7.93 billion in revenue each year. The medical equipment provider earns $-379,200,000.00 in net income (profit) each year or $7.64 on an earnings per share basis. Zimmer Biomet employs 19,000 workers across the globe.View Additional Information About Zimmer Biomet.

What is Zimmer Biomet's official website?

The official website for Zimmer Biomet is http://www.zimmerbiomet.com/.

How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]


MarketBeat Community Rating for Zimmer Biomet (NYSE ZBH)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  726 (Vote Outperform)
Underperform Votes:  603 (Vote Underperform)
Total Votes:  1,329
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet and other stocks. Vote "Outperform" if you believe ZBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel